logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
13/05/2025
Barclays: Maintains a rating of hold for Iovance Biotherapeutics (IOVA.US), adjusting it from hold to buy, with a target price adjusted from $5.00 to $4.00.
Latest
6 m ago
U.S. Secretary of State Pompeo: The U.S. State Department is sanctioning three Iranian individuals and an Iranian entity affiliated with Iran's Defense Innovation and Research Organization.
7 m ago
U.S. April tariff revenue soars, Trump's new trade policies show results
9 m ago
Standard & Poor's Global Ratings has given NextEra Capital Holdings a "BBB" rating for its proposed issuance of subordinated notes.
9 m ago
Standard & Poor's Global Ratings (S&PGR) has assigned a "BBB" rating to the subordinated notes planned for issuance by NextEra Capital Holdings.
12 m ago
U.S. Securities and Exchange Commission: May undergo comprehensive reforms of rules for cryptocurrency brokers.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.